A Multicenter, Randomized, Double-Blind, Parallel Arm, 12-Week Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin Combination Tablet Versus Atorvastatin in Elderly Patients With Hypercholesterolemia at Moderately High Risk and High Risk for CHD To assess the percent change from baseline in LDL-C levels after 12 weeks of treatment at the usual start dose comparisons of ezetimibe/simvastatin 10/20 mg versus atorvastatin 10 mg, and ezetimibe/si...

• Country None
• organs None
• Specialty None

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Dose-Ranging Study of L-000796568 in Postmenopausal Women With Overactive Bladder In postmenopausal women with overactive bladder: (1) To investigate a dose-related reduction, in average number of daily micturitions after 8 weeks of treatment with L 000796568 (375, 125, or 50 mg on...

• Country None
• organs None
• Specialty None